SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 730.70 |
| Enterprise Value ($M) | 609.93 |
| Book Value ($M) | 110.92 |
| Book Value / Share | 1.30 |
| Price / Book | 6.59 |
| NCAV ($M) | 110.92 |
| NCAV / Share | 1.30 |
| Price / NCAV | 6.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -0.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.45 |
| Current Ratio | 9.45 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 124.04 |
| Assets | 124.04 |
| Liabilities | 13.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -50.59 |
| Net Income | -43.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -30.81 |
| Cash from Investing | 0.00 |
| Cash from Financing | 11.97 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.31 | 5.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 198,523 | 634,985 | 31.26 | |
| 158,845 | 550,027 | 28.88 | |
| 212,248 | 646,181 | 32.85 | |
| 321,295 | 1,066,623 | 30.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATHA – Athira Pharma, Inc. | ATRA – Atara Biotherapeutics, Inc. |
| AVIR – Atea Pharmaceuticals, Inc. | BBIO – BridgeBio Pharma, Inc. |
| BCRX – BioCryst Pharmaceuticals, Inc. |